Senate Passes Aid Package

Here’s what you need to know: The Senate passes a $2 trillion stimulus plan. ImageThe Senate passed emergency coronavirus legislation on Capitol Hill on Wednesday.Credit…Anna Moneymaker/The New York Times The Senate voted unanimously on Wednesday to approve a sweeping, $2 trillion fiscal measure to shore up the United States economy as it weathers the devastation…

Details

16 Postpartum Swimsuits That Cater to New Moms

Courtesy of Brand Here’s the thing about #mombod, #momlife, or #mom-fill-in-the-blank: There’s no such thing as one-size-fits-all when it comes to the insane, unpredictable, gut-wrenchingly wonderful experience of having a child. The emotional, mental, and physical factors all vary wildly, and I promise—you’re setting yourself up for something bad if you go down the curvy,…

Details

Missing link in coronavirus jump from bats to humans could be pangolins, not snakes

As scientists scramble to learn more about the SARS-CoV-2 coronavirus, two recent studies of the virus’ genome reached controversial conclusions: namely, that snakes are intermediate hosts of the new virus, and that a key coronavirus protein shares “uncanny similarities” with an HIV-1 protein. Now, a study in ACS’ Journal of Proteome Research refutes both ideas…

Details

FDA approves ozanimod, a drug invented at Scripps Research, for multiple sclerosis

LA JOLLA, CA — The U.S. Food and Drug Administration has approved ozanimod, an immune-modulating therapy invented at Scripps Research, for the treatment of adults with relapsing forms of multiple sclerosis. The drug is also in advanced clinical development for adults and children with moderate-to-severe ulcerative colitis and Crohn’s disease. In patient studies supporting ozanimod’s…

Details

Mount Sinai researchers unveil mechanisms to prevent Crohn’s disease

(New York, NY – March 26, 2020) – In a series of four studies published today in Gastroenterology, a journal of the American Gastroenterological Association, Mount Sinai inflammatory bowel disease (IBD) researchers, describe the identification of predictive tools and a new understanding of environmental factors that trigger IBD. “Early identification of individuals at high…

Details

Moffitt researchers discover novel role of specific histone deacetylase in lung cancer

TAMPA, Fla. – The survival rates for patients with non-small cell lung cancer (NSCLC) have improved greatly over the past decade thanks to several new targeted treatment options for patients. However, lung cancer still remains the number one cause of cancer-related morality, leading to approximately 154,000 deaths each year in the United States. Many patients…

Details